Halozyme Therapeutics, Inc. (HALO)
FlaggedUS listed · Healthcare · Biotechnology
This page tracks Halozyme Therapeutics, Inc. (HALO) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews HALO against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
New to these indicators? RSI, MACD, and moving averages explained — plus how AI forecasting works.
Latest AI Analysis
Updated Oct 12, 2026Screen strength 2.1Price sits above both the SMA-50 ($105.65) and the rising SMA-200 ($79.42), a 43.45% one-year CAGR, and 41% revenue growth, which together support the pre-screen's long bias. The risks to verify are a negative MACD histogram (-0.684) with no fresh crossover, a 1-year Sharpe of 0.94 just under the 1.0 threshold, and EPS down 23.5% year over year. Price is also about 4% below the 52-week high of $116.84 after a 9/18 volume spike of 10.2M shares, and analyst targets range from $78 to $130.
HALO AI Signal Track Record
Recent scanner signals for Halozyme Therapeutics, Inc.. Each is a point-in-time AI assessment, not a guarantee of future performance.
| Date | Signal | Screen strength | Price at signal |
|---|---|---|---|
| Oct 12, 2026 | Flagged | 2.1 | $112.11 |
| Oct 12, 2026 | Flagged | 2.1 | $112.27 |
| Oct 12, 2026 | Flagged | 2.1 | $111.95 |
| Oct 12, 2026 | Flagged | 2.1 | $111.46 |
HALO — Frequently Asked Questions
Is Halozyme Therapeutics, Inc. (HALO) a buy right now?
As of October 12, 2026, StockTracker AI's screen flags HALO as Flagged, with a ±1.9% typical 3-day move, based on its multi-factor technical screen and AI review. This is a technical screen and informational analysis, not financial advice or a recommendation to trade — confirm it against your own research and risk tolerance.
What is HALO's RSI?
HALO's 14-day RSI was 53.8 at the last scan — in neutral territory. RSI above 70 is generally considered overbought and below 30 oversold; the 40–60 band is neutral and is best read alongside trend and momentum rather than on its own.
What is the AI price forecast for HALO?
StockTracker AI generates a probability-weighted 30-day price forecast for HALO — a mathematical baseline (regression on recent prices) adjusted by an AI model for news, earnings proximity, and the current macro regime, with bull/base/bear scenarios. Sign in to generate the latest forecast.
How does StockTracker AI analyze HALO?
Each scan screens HALO on momentum, RSI, MACD, moving-average posture, Sharpe ratio, and 1-year CAGR to build a composite score, then a frontier AI model reviews the full picture — fundamentals, macro context, and recent news — to confirm or challenge the signal before it's surfaced.
Get the full picture for HALO — free.
Add HALO to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Related stocks in Healthcare
Get scanner alerts and AI forecasts for HALO
Free tier includes daily AI analysis, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →